Location History:
- Vancouver, CA (1999 - 2011)
- Richmond, CA (2010 - 2019)
Company Filing History:
3 out of 8 
2 out of 51 
2 out of 8 
Years Active: 1999-2019
Title: Innovator Shoukat Dedhar: Pioneering Advances in Cancer Research
Introduction: Shoukat Dedhar, an accomplished inventor located in Richmond, CA, has made significant contributions to cancer research through his innovative work. With a remarkable portfolio of 12 patents, his groundbreaking inventions are pivotal for the future of cancer treatment and diagnosis.
Latest Patents: Two of Dedhar's most notable recent patents include methods and compositions related to cancer stem cells. The first patent, titled "Carbonic anhydrase IX-related markers and use thereof," details methods for detecting the presence of cancer stem cells and their applications in cancer prognosis, risk evaluation of metastasis, identifying drug candidates, and assessing treatment efficacy. Additionally, this patent encompasses kits useful for cancer stem cell detection, as well as therapeutic strategies employing CAIX inhibitors.
The second patent, "Sulfonamide compounds for inhibition of metastatic tumor growth," presents therapeutic ureido-sulfonamide compositions that selectively inhibit carbonic anhydrases CAIX and CAXII. These compounds have demonstrated effectiveness in inhibiting hypoxic tumor growth, suppressing metastasis, and depleting cancer stem cells in mammals.
Career Highlights: Throughout his career, Shoukat Dedhar has collaborated with leading health institutions, notably Sunnybrook Health Sciences Centre. His work there has been instrumental in integrating innovative research into practical applications for cancer treatment.
Collaborations: Dedhar has worked alongside esteemed colleagues such as Greg Hannigan and Paul Christopher McDonald, contributing to the advancement of cancer research and therapeutic methodologies.
Conclusion: Shoukat Dedhar stands as a prominent figure in the field of cancer research, with a considerable number of patents that reflect his dedication to improving patient outcomes. His innovative approaches to cancer treatment demonstrate the potential for significant advancements in medical science and the ongoing fight against cancer.